Treatment of a Patient with Chronic Immune Thrombocytopenic Purpura with Rituximab and Monitoring by Flow Cytometric Analysis

Publisher： Karger

E-ISSN： 1421-9662|111|4|221-224

ISSN： 0001-5792

Source： Acta Haematologica, Vol.111, Iss.4, 2004-05, pp. : 221-224

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Management of Chronic Childhood Immune Thrombocytopenic Purpura: AIEOP Consensus Guidelines

By  

Acta Haematologica, Vol. 123, Iss. 2, 2009-12 ,pp. : 96-109

Karger

Access to resources Recommend Favorite

Thrombotic Thrombocytopenic Purpura during Interferon Alpha Treatment for Chronic Myelogenous Leukemia

By  

Acta Haematologica, Vol. 102, Iss. 3, 2004-11 ,pp. : 160-162

Karger

Access to resources Recommend Favorite

Rituximab in Thrombotic Thrombocytopenic Purpura: Medical and Financial Benefits

By  

Acta Haematologica, Vol. 134, Iss. 3, 2015-05 ,pp. : 168-169

Karger

Access to resources Recommend Favorite

Intracranial Hemorrhage in Acute and Chronic Childhood Immune Thrombocytopenic Purpura over a Ten-Year Period: An Egyptian Multicenter Study

By  

Acta Haematologica, Vol. 123, Iss. 1, 2009-12 ,pp. : 59-63

Karger

Access to resources Recommend Favorite

5- to 16-Year Follow-Up following Splenectomy in Chronic Immune Thrombocytopenic Purpura in Children

By  

Acta Haematologica, Vol. 110, Iss. 1, 2003-09 ,pp. : 20-24

Karger

Access to resources Recommend Favorite